Article - 04/03/2013 TellTargeting Medical GmbH – targeted chemotherapy using CARL® The needs of cancer patients are clear chemotherapies that are as gentle as possible associated with minimal adverse effects and have a rapid effect. This is often difficult to achieve because the drug that stops tumour growth needs to remain in the body for a certain amount of time during which time it damages cancerous as well as healthy structures. Dr. Gerhard Pütz and Dr. Jürgen Eckes founded the company TellTargeting Medical GmbH Co. KG…https:////www.gesundheitsindustrie-bw.de/en/article/news/telltargeting-medical-gmbh-targeted-chemotherapy-using-carl
Article - 11/02/2013 REGiNA – the health region for regenerative medicine REGiNA is a users’ centre for regenerative medicine in the area bordered by the cities of Stuttgart and Tübingen and the Neckar-Alb region. It was established with the aim of translating a variety of advanced regenerative methods into broad clinical application. Providing a diverse and broad range of information, REGiNA is focused on making new treatment possibilities and the opportunities created by regenerative medicine known to doctors,…https:////www.gesundheitsindustrie-bw.de/en/article/news/regina-the-health-region-for-regenerative-medicine
Dossier - 20/12/2012 Medical technology – serving healthcare Modern healthcare would be impossible without medical technology. The achievements in medical technology are indispensable for our health and quality of life. The range of medical technology available covers surgical instruments and implants to diagnostic methods and medical devices.https:////www.gesundheitsindustrie-bw.de/en/article/dossier/medical-technology-serving-healthcare
Article - 17/12/2012 Medicyte GmbH – gold standard for human cells Medicyte GmbH is a life sciences company located in the city of Heidelberg. It focuses primarily on the production of quasi-primary human cells of the highest quality and in virtually unlimited quantity. MediCyte’s goal is to establish its proprietary cell proliferation technologies as gold standard for the use of human cells and cell products in research, development and cell therapy.https:////www.gesundheitsindustrie-bw.de/en/article/news/medicyte-gmbh-gold-standard-for-human-cells
Article - 17/12/2012 The ablation of nerves along the renal artery – a novel treatment option in the field of cardiology High blood pressure can normally be treated effectively with medicines. However, some patients do not respond to medicinal treatment despite several different drugs being used. Renal denervation (RDN), a novel catheter-based procedure, seems to have become a promising alternative to controlling hypertension with drugs. Professor Dr. Axel Bauer from the Tübingen University Hospital believes that this method can even be used for a much wider range…https:////www.gesundheitsindustrie-bw.de/en/article/news/the-ablation-of-nerves-along-the-renal-artery-a-novel-treatment-option-in-the-field-of-cardiology
Article - 22/10/2012 syneed imaging: precise visualisation of functional tissue properties Functional medical imaging modalities are of great significance in modern medical diagnostics. Existing ways of diagnosing diseases are now being expanded with the arrival of the innovative parameter imaging method. syneed imaging uses proprietary highly sensitive software for the analysis of dynamic image data. This software complements standard methods such as computed tomography and magnetic resonance imaging and increases the significance of…https:////www.gesundheitsindustrie-bw.de/en/article/news/syneed-imaging-precise-visualisation-of-functional-tissue-properties
Article - 15/10/2012 Carmen Ruiz de Almodóvar and the link between the nervous and vascular systems Dr. Carmen Ruiz de Almodóvar from the Heidelberg University Biochemistry Centre has been awarded an ERC Starting Grant to study the molecular similarities between the nervous and vascular systems. The researcher showed that angiogenic factors such as VEGF also control the growth of neuronal cells and may be responsible for disorders in the development of nervous systems.https:////www.gesundheitsindustrie-bw.de/en/article/news/carmen-ruiz-de-almod-var-and-the-link-between-the-nervous-and-vascular-systems
Article - 08/10/2012 A systems biology approach to understanding tumour growth Researchers at the Center Systems Biology in Stuttgart are developing multi-scale models of tumour growth with the aim of predicting how drugs spread and disperse in the tissue. The simulations can also take into account potential effects of pharmacological compounds and irradiation. The method will benefit researchers and clinicians by assisting them in their efforts to develop more efficient therapies. https:////www.gesundheitsindustrie-bw.de/en/article/news/a-systems-biology-approach-to-understanding-tumour-growth
Article - 24/09/2012 MTS: Shock wave technology for the therapy of diabetic foot ulcer Almost 15 percent of an estimated seven million diabetes mellitus patients in Germany suffer from diabetic foot syndrome DFS. It is associated with damage to the foot nerves and blood vessels as well as the presence of chronic wounds which in thousands of cases every year precede lower leg amputations. The Konstanz-based company MTS Medical has developed a shock wave therapy system that has the potential to considerably reduce the number of…https:////www.gesundheitsindustrie-bw.de/en/article/news/mts-shock-wave-technology-for-the-therapy-of-diabetic-foot-ulcer
Article - 23/04/2012 Vascular grafts: biomolecules to prevent blood vessels from reclosing Obstructed blood vessels can be operated on and adequate blood flow restored. However, stents and bypasses are often subject to high reclosure rates. Excessive immune reactions close to where the intervention took place might prevent the regeneration of adjacent vessel walls and even lead to reclosure. New interventions involving RNA interference seem to be a way out of this dilemma.https:////www.gesundheitsindustrie-bw.de/en/article/news/vascular-grafts-biomolecules-to-prevent-blood-vessels-from-reclosing
Article - 19/03/2012 Calcium channels – about channel proteins and why we forget things The controlled transport of calcium across cell membranes is crucial for many biological processes including the transfer of information into the brain kidney function and the rhythmic activity of the heart muscle. A team led by Prof. Dr. Norbert Klugbauer at the University of Freiburg is focused on elucidating the function of calcium channels the proteins that regulate them and the effects on learning and memory. The researchers are…https:////www.gesundheitsindustrie-bw.de/en/article/news/calcium-channels-about-channel-proteins-and-why-we-forget-things
Article - 19/03/2012 Quantification of the morphology of human blood vessels from 3D tomographic image data “QuantVessel”, an innovative approach designed to accurately determine the size and shape of blood vessels from 3D tomographic images, enables vascular diseases to be diagnosed more reliably and makes surgery more effective. The project is being carried out by researchers from the BioQuant centre at Universität Heidelberg and Deutsches Krebsforschungszentrum (German Cancer Research Center) and funded by the German Research Foundation (DFG). It…https:////www.gesundheitsindustrie-bw.de/en/article/news/quantification-of-the-morphology-of-human-blood-vessels-from-3d-tomographic-image-data
Dossier - 12/03/2012 Regenerative medicine makes use of patients’ own resources Regenerative medicine offers new therapeutic options for many diseases in which organ function or structure are damaged or lost. The majority of regenerative therapies involve cell-based methods that are often combined with innovative biomaterials. Regenerative therapies combine know-how from the biosciences with state-of-the-art medical technology and also benefit from progress in the engineering and material sciences.https:////www.gesundheitsindustrie-bw.de/en/article/dossier/regenerative-medicine-makes-use-of-patients-own-resources
Article - 20/02/2012 Klaus Pfizenmaier: bridging the fields between immunology and biomedicine Prof. Dr. Klaus Pfizenmaier has been focusing on cytokines, and in particular on the tumour necrosis factor TNF, for the last 25 years. Pfizenmaier and his team of researchers at the Institute of Cell Biology and Immunology at the University of Stuttgart have unravelled numerous facets of TNF, which is a key and versatile signalling molecule. These discoveries have led to the development of groundbreaking therapy concepts and drug candidates for…https:////www.gesundheitsindustrie-bw.de/en/article/news/klaus-pfizenmaier-bridging-the-fields-between-immunology-and-biomedicine
Press release - 30/11/2011 Researchers are challenging a common model of immunology Up to now, scientists have assumed that mast cells, a certain type of immune cells, play a central role in the development of autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. Current studies conducted at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have now provided evidence to refute this assumption. Now it is only the mast cells’ central function in allergies that remains undisputed.https:////www.gesundheitsindustrie-bw.de/en/article/press-release/researchers-are-challenging-a-common-model-of-immunology
Article - 28/11/2011 Oliver Schilling – the function of proteases in molecular processes The biologist Dr. Oliver Schilling from the University of Freiburg has co-developed methods that improve our understanding of the function of proteases in molecular processes. His research group is currently investigating cellular processes that are regulated by these proteolytic enzymes and looking into issues such as the key role they play in tumour development.https:////www.gesundheitsindustrie-bw.de/en/article/news/oliver-schilling-the-function-of-proteases-in-molecular-processes
Press release - 03/10/2011 Astonishing discovery: iron-overloading of macrophages is the cause of venous leg ulcers Around three to five per cent of people in industrial nations suffer from chronic venous leg ulcers. Elderly people are particularly prone to developing these chronic wounds. A dermatologist from Ulm has now discovered the reason why chronic venous leg ulcers fail to heal even after months or years. The scientific community is astonished by the new findings.https:////www.gesundheitsindustrie-bw.de/en/article/press-release/astonishing-discovery-iron-overloading-of-macrophages-is-the-cause-of-venous-leg-ulcers
Press release - 30/09/2011 Blood Vessels from Your Printer Researchers have been working at growing tissue and organs in the laboratory for a long time. These days, tissue engineering enables us to build up artificial tissue, although science still hasn’t been successful with larger organs. Now, researchers at Fraunhofer are applying new techniques and materials to come up with artificial blood vessels in their BioRap project that will be able to supply artificial tissue and maybe even complex organs in…https:////www.gesundheitsindustrie-bw.de/en/article/press-release/blood-vessels-from-your-printer
Article - 25/07/2011 Christian Thoma – the control of translation enables the rapid regulation of cellular processes Heisenberg fellow PD Dr. Christian Thoma from the Freiburg University Medical Centre has been focusing on the regulation of translation for a number of years and has established a method that enables him to investigate translation on the molecular level. Thoma and his team have come a step closer to their goal of finding targets for the therapy of cancer and hepatitis C.https:////www.gesundheitsindustrie-bw.de/en/article/news/christian-thoma-the-control-of-translation-enables-the-rapid-regulation-of-cellular-processes
Article - 18/07/2011 Titanium screws and stem cells for dental implants How are we supposed to chew and smile when the tooth fairy comes to fetch our second set of teeth? When it’s difficult to tell the difference between modern tooth implants and real teeth in both technical and aesthetical terms, people who lose their teeth due to accidents or age very quickly regain their smile. However, there needs to be enough bone to hold and support the implant. Prof. Dr. Dr. Ralf Gutwald and his team in the Department of Oral…https:////www.gesundheitsindustrie-bw.de/en/article/news/titanium-screws-and-stem-cells-for-dental-implants
Article - 04/07/2011 The adhesion of cells to the endothelium and to artificial surfaces Professor Stefan W. Schneider from the Mannheim Medical Faculty is investigating the function of the vascular endothelium and its interaction with blood and tumour cells using microfluidics methods that enable him to measure the adhesion of cells to the walls of blood vessels under physiological flow conditions. As part of an interdisciplinary project, he is investigating the characteristics of wafer-thin surfaces covered with living cells, which…https:////www.gesundheitsindustrie-bw.de/en/article/news/the-adhesion-of-cells-to-the-endothelium-and-to-artificial-surfaces
Article - 27/06/2011 New therapeutic approaches: nitric oxide for the treatment of brain tumours Researchers led by neurosurgeon Dr. Astrid Weyerbrock from the Freiburg University Medical Centre are working on the improvement of therapies for the effective treatment of glioblastomas that involve deciphering the biological mechanisms that lead to these complex brain tumours. They are using a volatile molecule that is also found in the earths atmosphere.https:////www.gesundheitsindustrie-bw.de/en/article/news/new-therapeutic-approaches-nitric-oxide-for-the-treatment-of-brain-tumours
Article - 23/05/2011 KIT researchers attempt to grow cardiomyocytes in Petri dishes Regenerative medicine specialists are aiming to be able to grow complete organs from stem cells some time in the future. However although the microscopically small cells are able to do many things they are not able to grow organs on their own. Dr. Alexandra Rolletschek and her team at the Karlsruhe Institute of Technology KIT are investigating how stem cells can be grown into heart muscle cells cardiomyocytes in Petri dishes. https:////www.gesundheitsindustrie-bw.de/en/article/news/kit-researchers-attempt-to-grow-cardiomyocytes-in-petri-dishes
Article - 21/02/2011 Hope for more effective brain tumour therapy Glioblastoma is the most common and most aggressive type of brain tumour in humans. It has a tendency to recur and it carries a bad prognosis. Intensive research into the molecular reaction chains involved in its pathogenesis has led to promising and effective treatment strategies.https:////www.gesundheitsindustrie-bw.de/en/article/news/hope-for-more-effective-brain-tumour-therapy
Press release - 28/11/2010 Cardiac catheter surgery for children and young adults without X-ray radiation Heart specialists and electrophysiologists from Tübingen University Hospital have succeeded for the first time in Germany in treating cardiac arrhythmia without the need for X-ray radiation. This was done through the selection of a new method to control the contact force between the catheter and the blood vessel and cardiac walls. The intervention was successfully carried out on a 16-year-old girl and is regarded as a very attractive alternative…https:////www.gesundheitsindustrie-bw.de/en/article/press-release/cardiac-catheter-surgery-for-children-and-young-adults-without-x-ray-radiation